Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen

Anna Giuliani, Steven A. Porcelli, Lucio Tentori, Grazia Graziani, Carla Testorelli, Salvatore P. Prete, Simona Bussini, Daniela Cappelletti, Michael B. Brenner, Enzo Bonmassar, Angelo Aquino

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Non-classical antigen-presentation by CD1 molecules expressed on cytokine-activated monocytes (CAM), and cell-mediated responses supported by double-negative (DN) and by CD8+ responder αβ T cells, are involved in host resistance against mycobacterial infections. The CD1b protein is responsible for presentation of non-peptide, lipid antigens to T cells. In this context, a pivotal role is played by induction of CD1b protein on the membrane of human monocytes activated by GM-CSF alone, and more efficiently by GM-CSF combined with IL-4. Rifampin (RFP), a drug which is extensively utilized for chemoprophylaxis or treatment of Mycobacterium tuberculosis, is known to reduce a number of B, or T cell-dependent responses. Therefore we undertook immunopharmacological studies on RFP, to determine the effects of this agent on human macrophage function, relative to antigen presentation by CD1b molecules and on DN T cell cytolytic function. The results showed that: (a) graded concentration of RFP (2 or 10 μg/ml) induced a significant increase of CD1b expression, in CAM as evaluated by FACS analysis; (b) RFP increased significantly the specific mAb binding to CD1b on CAM surface; (c) treatment of effector cells with RFP did not reduce DN T cell-mediated cytolysis against lymphoblastoid cells transfected with CD1b cDNA (C1R b6 cells), pulsed with M. tuberculosis. These results suggest that RFP could be of potential value in improving mycobacterial antigen presentation without impairing responder T cell function.

Original languageEnglish (US)
Pages (from-to)985-994
Number of pages10
JournalLife Sciences
Volume63
Issue number12
DOIs
StatePublished - Aug 14 1998
Externally publishedYes

Fingerprint

T-cells
Glycolipids
Rifampin
Mycobacterium
T-Lymphocytes
Antigens
Monocytes
Antigen Presentation
Granulocyte-Macrophage Colony-Stimulating Factor
Cytokines
Mycobacterium tuberculosis
CD1 Antigens
Molecules
Macrophages
Chemoprevention
Interleukin-4
Membrane Proteins
Proteins
B-Lymphocytes
Complementary DNA

Keywords

  • CD1b
  • Double negative T cells
  • Rifampin
  • Tuberculosis

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen. / Giuliani, Anna; Porcelli, Steven A.; Tentori, Lucio; Graziani, Grazia; Testorelli, Carla; Prete, Salvatore P.; Bussini, Simona; Cappelletti, Daniela; Brenner, Michael B.; Bonmassar, Enzo; Aquino, Angelo.

In: Life Sciences, Vol. 63, No. 12, 14.08.1998, p. 985-994.

Research output: Contribution to journalArticle

Giuliani, A, Porcelli, SA, Tentori, L, Graziani, G, Testorelli, C, Prete, SP, Bussini, S, Cappelletti, D, Brenner, MB, Bonmassar, E & Aquino, A 1998, 'Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen', Life Sciences, vol. 63, no. 12, pp. 985-994. https://doi.org/10.1016/S0024-3205(98)00360-9
Giuliani, Anna ; Porcelli, Steven A. ; Tentori, Lucio ; Graziani, Grazia ; Testorelli, Carla ; Prete, Salvatore P. ; Bussini, Simona ; Cappelletti, Daniela ; Brenner, Michael B. ; Bonmassar, Enzo ; Aquino, Angelo. / Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen. In: Life Sciences. 1998 ; Vol. 63, No. 12. pp. 985-994.
@article{d4146bb04efb4004843fef3b76d464c9,
title = "Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen",
abstract = "Non-classical antigen-presentation by CD1 molecules expressed on cytokine-activated monocytes (CAM), and cell-mediated responses supported by double-negative (DN) and by CD8+ responder αβ T cells, are involved in host resistance against mycobacterial infections. The CD1b protein is responsible for presentation of non-peptide, lipid antigens to T cells. In this context, a pivotal role is played by induction of CD1b protein on the membrane of human monocytes activated by GM-CSF alone, and more efficiently by GM-CSF combined with IL-4. Rifampin (RFP), a drug which is extensively utilized for chemoprophylaxis or treatment of Mycobacterium tuberculosis, is known to reduce a number of B, or T cell-dependent responses. Therefore we undertook immunopharmacological studies on RFP, to determine the effects of this agent on human macrophage function, relative to antigen presentation by CD1b molecules and on DN T cell cytolytic function. The results showed that: (a) graded concentration of RFP (2 or 10 μg/ml) induced a significant increase of CD1b expression, in CAM as evaluated by FACS analysis; (b) RFP increased significantly the specific mAb binding to CD1b on CAM surface; (c) treatment of effector cells with RFP did not reduce DN T cell-mediated cytolysis against lymphoblastoid cells transfected with CD1b cDNA (C1R b6 cells), pulsed with M. tuberculosis. These results suggest that RFP could be of potential value in improving mycobacterial antigen presentation without impairing responder T cell function.",
keywords = "CD1b, Double negative T cells, Rifampin, Tuberculosis",
author = "Anna Giuliani and Porcelli, {Steven A.} and Lucio Tentori and Grazia Graziani and Carla Testorelli and Prete, {Salvatore P.} and Simona Bussini and Daniela Cappelletti and Brenner, {Michael B.} and Enzo Bonmassar and Angelo Aquino",
year = "1998",
month = "8",
day = "14",
doi = "10.1016/S0024-3205(98)00360-9",
language = "English (US)",
volume = "63",
pages = "985--994",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen

AU - Giuliani, Anna

AU - Porcelli, Steven A.

AU - Tentori, Lucio

AU - Graziani, Grazia

AU - Testorelli, Carla

AU - Prete, Salvatore P.

AU - Bussini, Simona

AU - Cappelletti, Daniela

AU - Brenner, Michael B.

AU - Bonmassar, Enzo

AU - Aquino, Angelo

PY - 1998/8/14

Y1 - 1998/8/14

N2 - Non-classical antigen-presentation by CD1 molecules expressed on cytokine-activated monocytes (CAM), and cell-mediated responses supported by double-negative (DN) and by CD8+ responder αβ T cells, are involved in host resistance against mycobacterial infections. The CD1b protein is responsible for presentation of non-peptide, lipid antigens to T cells. In this context, a pivotal role is played by induction of CD1b protein on the membrane of human monocytes activated by GM-CSF alone, and more efficiently by GM-CSF combined with IL-4. Rifampin (RFP), a drug which is extensively utilized for chemoprophylaxis or treatment of Mycobacterium tuberculosis, is known to reduce a number of B, or T cell-dependent responses. Therefore we undertook immunopharmacological studies on RFP, to determine the effects of this agent on human macrophage function, relative to antigen presentation by CD1b molecules and on DN T cell cytolytic function. The results showed that: (a) graded concentration of RFP (2 or 10 μg/ml) induced a significant increase of CD1b expression, in CAM as evaluated by FACS analysis; (b) RFP increased significantly the specific mAb binding to CD1b on CAM surface; (c) treatment of effector cells with RFP did not reduce DN T cell-mediated cytolysis against lymphoblastoid cells transfected with CD1b cDNA (C1R b6 cells), pulsed with M. tuberculosis. These results suggest that RFP could be of potential value in improving mycobacterial antigen presentation without impairing responder T cell function.

AB - Non-classical antigen-presentation by CD1 molecules expressed on cytokine-activated monocytes (CAM), and cell-mediated responses supported by double-negative (DN) and by CD8+ responder αβ T cells, are involved in host resistance against mycobacterial infections. The CD1b protein is responsible for presentation of non-peptide, lipid antigens to T cells. In this context, a pivotal role is played by induction of CD1b protein on the membrane of human monocytes activated by GM-CSF alone, and more efficiently by GM-CSF combined with IL-4. Rifampin (RFP), a drug which is extensively utilized for chemoprophylaxis or treatment of Mycobacterium tuberculosis, is known to reduce a number of B, or T cell-dependent responses. Therefore we undertook immunopharmacological studies on RFP, to determine the effects of this agent on human macrophage function, relative to antigen presentation by CD1b molecules and on DN T cell cytolytic function. The results showed that: (a) graded concentration of RFP (2 or 10 μg/ml) induced a significant increase of CD1b expression, in CAM as evaluated by FACS analysis; (b) RFP increased significantly the specific mAb binding to CD1b on CAM surface; (c) treatment of effector cells with RFP did not reduce DN T cell-mediated cytolysis against lymphoblastoid cells transfected with CD1b cDNA (C1R b6 cells), pulsed with M. tuberculosis. These results suggest that RFP could be of potential value in improving mycobacterial antigen presentation without impairing responder T cell function.

KW - CD1b

KW - Double negative T cells

KW - Rifampin

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0032516533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032516533&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(98)00360-9

DO - 10.1016/S0024-3205(98)00360-9

M3 - Article

C2 - 9749821

AN - SCOPUS:0032516533

VL - 63

SP - 985

EP - 994

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 12

ER -